NO325780B1 - Alkyleter-derivater eller deres salter, fremgangsmater for fremstilling av slike samt farmasoytiske preparater inneholdende slike - Google Patents

Alkyleter-derivater eller deres salter, fremgangsmater for fremstilling av slike samt farmasoytiske preparater inneholdende slike Download PDF

Info

Publication number
NO325780B1
NO325780B1 NO20041531A NO20041531A NO325780B1 NO 325780 B1 NO325780 B1 NO 325780B1 NO 20041531 A NO20041531 A NO 20041531A NO 20041531 A NO20041531 A NO 20041531A NO 325780 B1 NO325780 B1 NO 325780B1
Authority
NO
Norway
Prior art keywords
group
ethoxy
benzothiophen
general formula
ring
Prior art date
Application number
NO20041531A
Other languages
English (en)
Norwegian (no)
Other versions
NO20041531L (no
Inventor
Tamotsu Takamatsu
Akihito Saitoh
Noboru Iwakami
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of NO20041531L publication Critical patent/NO20041531L/no
Publication of NO325780B1 publication Critical patent/NO325780B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/12Oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
NO20041531A 2001-10-19 2004-04-15 Alkyleter-derivater eller deres salter, fremgangsmater for fremstilling av slike samt farmasoytiske preparater inneholdende slike NO325780B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001321381 2001-10-19
PCT/JP2002/010827 WO2003035647A1 (fr) 2001-10-19 2002-10-18 Derives ou sels d'ether d'alkyle

Publications (2)

Publication Number Publication Date
NO20041531L NO20041531L (no) 2004-04-15
NO325780B1 true NO325780B1 (no) 2008-07-14

Family

ID=19138603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041531A NO325780B1 (no) 2001-10-19 2004-04-15 Alkyleter-derivater eller deres salter, fremgangsmater for fremstilling av slike samt farmasoytiske preparater inneholdende slike

Country Status (23)

Country Link
US (4) US7087594B2 (da)
EP (1) EP1437353B1 (da)
JP (1) JP4398247B2 (da)
KR (1) KR100956990B1 (da)
CN (2) CN101643470B (da)
AT (1) ATE364604T1 (da)
AU (1) AU2002344107B2 (da)
BR (1) BRPI0213393B8 (da)
CA (1) CA2464358C (da)
CY (1) CY1106714T1 (da)
DE (1) DE60220694T2 (da)
DK (1) DK1437353T3 (da)
ES (1) ES2287324T3 (da)
HU (1) HU230407B1 (da)
IL (2) IL161308A0 (da)
MX (1) MXPA04003541A (da)
NO (1) NO325780B1 (da)
NZ (1) NZ532328A (da)
PL (2) PL215264B1 (da)
PT (1) PT1437353E (da)
RO (1) RO122203B1 (da)
WO (1) WO2003035647A1 (da)
ZA (1) ZA200402806B (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RO122203B1 (ro) * 2001-10-19 2009-02-27 Toyama Chemical Co., Ltd. Derivaţi de alchil eter şi sărurile acestora
EP2389937B1 (en) 2002-06-14 2018-08-15 Toyama Chemical Co., Ltd. Medicinal composition for improving brain function
KR101096528B1 (ko) * 2003-04-17 2011-12-20 토야마 케미칼 컴퍼니 리미티드 알킬에테르 유도체 또는 그 염을 함유하는 망막신경질환의예방·치료제
AU2011204959B2 (en) * 2005-03-28 2012-04-12 Toyama Chemical Co., Ltd. Process for production of 1-(3-(2-(1-benzothiophen-5-YL)- ethoxy)propyl)azetidin-3-ol or salts thereof
AU2006229271B2 (en) * 2005-03-28 2012-02-09 Toyama Chemical Co., Ltd. Process for production of 1-(3-(2-(1-benzothiophen-5-YL)- ethoxy)propyl)azetidin-3-ol or salts thereof
JP4902247B2 (ja) * 2005-04-08 2012-03-21 富山化学工業株式会社 2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体
JP2006328058A (ja) * 2005-04-27 2006-12-07 Toyama Chem Co Ltd 2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体
KR101374593B1 (ko) 2006-04-26 2014-03-17 토야마 케미칼 컴퍼니 리미티드 알킬에테르 유도체 또는 그 염을 함유하는 신경세포 신생유도제 및 정신장해 치료제
US8119625B2 (en) 2006-04-26 2012-02-21 Toyama Chemical Co., Ltd. Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
US8173633B2 (en) * 2006-08-04 2012-05-08 Toyama Chemical Co., Ltd. Protein kinase C activity enhancer containing alkyl ether derivative or salt thereof
JP5552424B2 (ja) 2008-05-28 2014-07-16 富山化学工業株式会社 新規なベンゾチオフェンオキシド誘導体またはその塩
TR201907882T4 (tr) 2012-02-22 2019-06-21 Fujifilm Toyama Chemical Co Ltd 1-(3-(2-(1-Benzotiofen-5-il)etoksi)propil)azetidin-3-olü veya onun tuzunu içeren katı farmasötik bileşim
PL3100725T3 (pl) * 2014-01-31 2020-11-16 Fujifilm Toyama Chemical Co., Ltd. Środek wzmacniający efekt rehabilitacji po uszkodzeniu nerwu zawierający pochodną eteru alkilowego lub jej sól
EP3308782B1 (en) * 2015-06-11 2022-01-19 Toyama Chemical Co., Ltd. Sigma-receptor binding agent
US11304928B2 (en) 2015-12-25 2022-04-19 Fujifilm Toyama Chemical Co., Ltd. Tablet comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof
US20190336476A1 (en) 2016-12-28 2019-11-07 Fujifilm Toyama Chemical Co., Ltd. Pharmaceutical composition
JP7176957B2 (ja) * 2016-12-28 2022-11-22 富士フイルム富山化学株式会社 外用組成物
JP7079209B2 (ja) 2016-12-28 2022-06-01 富士フイルム富山化学株式会社 医薬組成物およびその製造方法
JP7057286B2 (ja) 2016-12-28 2022-04-19 富士フイルム富山化学株式会社 医薬組成物
CN116473962A (zh) 2017-06-02 2023-07-25 富士胶片富山化学株式会社 脑萎缩预防或治疗剂
JP7133547B2 (ja) 2017-06-02 2022-09-08 富士フイルム富山化学株式会社 脊髄小脳変性症予防または治療剤
JP7370859B2 (ja) 2017-06-02 2023-10-30 富士フイルム富山化学株式会社 タウオパチー予防または治療剤
EP3636262A4 (en) 2017-06-02 2020-06-10 FUJIFILM Toyama Chemical Co., Ltd. AGENT FOR PREVENTING OR TREATING ALZHEIMER-LIKE DEMENTIA
SG11201911519UA (en) * 2017-06-02 2020-01-30 Fujifilm Toyama Chemical Co Ltd AGENT FOR REDUCING AMOUNT OF AMYLOID ß PROTEIN
US11548878B2 (en) 2017-10-30 2023-01-10 Fujifilm Toyama Chemical Co., Ltd. Emopamil binding protein binding agent and use thereof
CN114853619B (zh) * 2022-05-19 2024-05-10 神隆医药(常熟)有限公司 一种适于工业化生产的n-甲基酪胺盐酸盐的制备方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01156973A (ja) 1987-09-04 1989-06-20 Tanabe Seiyaku Co Ltd ベンゾフラン誘導体
JP2887492B2 (ja) 1990-02-05 1999-04-26 富山化学工業株式会社 1,2―エタンジオール誘導体およびその塩
JP3044055B2 (ja) 1990-08-09 2000-05-22 富山化学工業株式会社 1,2―エタンジオール誘導体およびその塩
DK74693D0 (da) 1993-06-23 1993-06-23 Novo Nordisk As Novel heterocyclic chemistry
JP3232830B2 (ja) 1993-11-30 2001-11-26 三菱電機株式会社 フレキシブルディスク装置のキャリッジ機構
JPH08268883A (ja) 1994-10-25 1996-10-15 Toyama Chem Co Ltd 1−フェニル−1,2−エタンジオール誘導体またはそ の塩を含有する神経成長因子の作用増強剤
EP0790246B1 (en) 1994-10-25 2002-01-16 Toyama Chemical Co., Ltd. Potentiator for nerve growth factor activity containing 1,2-ethanediol derivative or salt thereof
UA59341C2 (uk) 1995-08-11 2003-09-15 Пфайзер, Інк. (1s,2s)-1-(4-гідроксифеніл)-2-(4-гідрокси-4-фенілпіперидин-1-іл)-1-пропанолметансульфонат тригідрат
AU7001796A (en) 1995-09-22 1997-04-09 Yoshitomi Pharmaceutical Industries, Ltd. Benzoic acid compounds and medicinal use thereof
DE19605610A1 (de) 1996-02-15 1997-08-21 Hoechst Ag Substituierte Thiophenylalkenylcarbonsäureguanidide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
AU1672597A (en) 1996-02-20 1997-09-10 Toyama Chemical Co. Ltd. Cerebral function ameliorant containing 1,2-ethanediol derivatives or salts thereof
WO1999031056A1 (fr) * 1997-12-12 1999-06-24 Toyama Chemical Co., Ltd. Derives d'ether alcoylique ou leurs sels, et antagonistes du calcium les contenant
JP4549452B2 (ja) 1997-12-12 2010-09-22 富山化学工業株式会社 アルキルエーテル誘導体またはその塩並びにそれらを含有するカルシウム拮抗剤
PL196773B1 (pl) 1999-06-11 2008-01-31 Toyama Chemical Co Ltd Pochodna N-alkiloksyalkilo-N,N-dialkiloaminy lub jej sole oraz środek zawierający ten związek stosowany do leczenia chorób neurodegeneratywnych
RO122203B1 (ro) 2001-10-19 2009-02-27 Toyama Chemical Co., Ltd. Derivaţi de alchil eter şi sărurile acestora
EP2389937B1 (en) 2002-06-14 2018-08-15 Toyama Chemical Co., Ltd. Medicinal composition for improving brain function
KR101096528B1 (ko) 2003-04-17 2011-12-20 토야마 케미칼 컴퍼니 리미티드 알킬에테르 유도체 또는 그 염을 함유하는 망막신경질환의예방·치료제
AU2006229271B2 (en) 2005-03-28 2012-02-09 Toyama Chemical Co., Ltd. Process for production of 1-(3-(2-(1-benzothiophen-5-YL)- ethoxy)propyl)azetidin-3-ol or salts thereof
KR101374593B1 (ko) 2006-04-26 2014-03-17 토야마 케미칼 컴퍼니 리미티드 알킬에테르 유도체 또는 그 염을 함유하는 신경세포 신생유도제 및 정신장해 치료제
US8119625B2 (en) 2006-04-26 2012-02-21 Toyama Chemical Co., Ltd. Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof
US8173633B2 (en) 2006-08-04 2012-05-08 Toyama Chemical Co., Ltd. Protein kinase C activity enhancer containing alkyl ether derivative or salt thereof
JP5552424B2 (ja) 2008-05-28 2014-07-16 富山化学工業株式会社 新規なベンゾチオフェンオキシド誘導体またはその塩

Also Published As

Publication number Publication date
CY1106714T1 (el) 2012-05-23
US7468443B2 (en) 2008-12-23
KR100956990B1 (ko) 2010-05-11
US20050070521A1 (en) 2005-03-31
CN101643470B (zh) 2012-08-01
AU2002344107B2 (en) 2007-11-01
DE60220694D1 (de) 2007-07-26
HUP0500017A3 (en) 2011-07-28
HUP0500017A2 (hu) 2005-04-28
BRPI0213393B8 (pt) 2021-05-25
EP1437353A4 (en) 2005-01-19
CN101643470A (zh) 2010-02-10
EP1437353B1 (en) 2007-06-13
JP4398247B2 (ja) 2010-01-13
US7087594B2 (en) 2006-08-08
USRE43676E1 (en) 2012-09-18
PL369601A1 (en) 2005-05-02
PT1437353E (pt) 2007-08-28
CN100500662C (zh) 2009-06-17
CN1571786A (zh) 2005-01-26
IL161308A0 (en) 2004-09-27
US20060194781A1 (en) 2006-08-31
PL402986A1 (pl) 2013-04-29
PL217872B1 (pl) 2014-08-29
US8129535B2 (en) 2012-03-06
ES2287324T3 (es) 2007-12-16
RO122203B1 (ro) 2009-02-27
BR0213393A (pt) 2005-01-11
JPWO2003035647A1 (ja) 2005-07-28
US20090111992A1 (en) 2009-04-30
DK1437353T3 (da) 2007-08-06
CA2464358A1 (en) 2003-05-01
NO20041531L (no) 2004-04-15
HU230407B1 (hu) 2016-04-28
ATE364604T1 (de) 2007-07-15
IL161308A (en) 2011-06-30
CA2464358C (en) 2011-05-24
MXPA04003541A (es) 2004-07-22
PL215264B1 (pl) 2013-11-29
WO2003035647A1 (fr) 2003-05-01
ZA200402806B (en) 2005-06-29
BRPI0213393B1 (pt) 2018-12-04
KR20040050919A (ko) 2004-06-17
EP1437353A1 (en) 2004-07-14
NZ532328A (en) 2005-07-29
DE60220694T2 (de) 2008-02-07

Similar Documents

Publication Publication Date Title
US7468443B2 (en) Alkyl ether derivatives or salts thereof
JP4642657B2 (ja) アルキルエーテル誘導体またはその塩を含有する網膜神経疾患の予防・治療剤
JP3202994B2 (ja) 選却的トロンビン抑制剤として有用な芳香族アミジン誘導体
HU186523B (en) Process for producing quinoline derivatives
JP4782961B2 (ja) N−アルコキシアルキル−n,n−ジアルキルアミン誘導体またはその塩、それらを含有する神経変性疾患の治療剤
JP5552424B2 (ja) 新規なベンゾチオフェンオキシド誘導体またはその塩
US5714502A (en) Piperidinylmethyloxazolidinones
CZ257794A3 (en) Cyclic amino derivatives
JP4061059B2 (ja) N−アルコキシアルキル−n−アルキルアミン誘導体またはその塩
EP0782987A1 (en) Indole derivatives

Legal Events

Date Code Title Description
MK1K Patent expired